SEC Form 4 · accession 0001615764-15-000002
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Iain McGill
Officer — SVP, Europe & Rest of World
Period of report
Nov 13, 2015
Accepted (ET)
Nov 17, 2015 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Nov 13, 2015 | S | 1,621 | $135.3717 | D | 20,346 | D | |
| Ordinary Shares | Nov 13, 2015 | S | 1,200 | $136.0829 | D | 19,146 | D |
Table II — derivative securities
No Table II lines on this filing.